 |
 |
 |
 |
|
 |
Treatment Next 25
|
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides in Combination with Poly-ICLC for Children with Newly Diagnosed Malignant or Intrinsic Brain Stem Gliomas (BSG) or Incompletely Resected Non-Brainstem High-Grade Gliomas (HGG) or Recurrent Unresectable Low-Grade Gliomas (LGG) or Recurrent High Grade Gliomas |
 |
Pittsburgh, PA |
 |
09/23/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
|
 |
Durham, NC |
 |
09/05/2009 |
 |
 |
 |
Details |
 |
Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases |
 |
Stanford, CA |
 |
09/01/2009 |
 |
 |
 |
 |
 |
Details |
 |
A phase II trial of PTK-787 in recurrent or progressive meningiomas |
 |
Cincinnati, OH |
 |
08/27/2009 |
 |
 |
 |
Details |
 |
Phase I/II Trial for Patients with Recurrent Resectable Glioblastoma Multiforme Using Surgery with Implantable BCNU Polmer Followed by Post-operative Irinotecan and Bevacizumab |
 |
Cincinnati, OH |
 |
08/27/2009 |
 |
 |
 |
 |
 |
Details |
 |
RTOG 0614 A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial of Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy |
 |
Cincinnati, OH |
 |
08/27/2009 |
 |
 |
 |
Details |
 |
RTOG 0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent |
 |
Cincinnati, OH |
 |
08/27/2009 |
 |
 |
 |
 |
 |
Details |
 |
ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant
Temozolomide in Patients with Malignant Glioma |
 |
San Francisco, CA |
 |
07/07/2009 |
 |
 |
 |
Details |
 |
A Phase II Safety and Tolerability Study of Avastin When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain |
 |
West Palm Beach, FL Charlotte, NC Durham, NC |
 |
06/16/2009 |
 |
 |
 |
 |
 |
Details |
 |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
 |
Oceanside, NY |
 |
05/20/2009 |
 |
 |
 |
Details |
 |
A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors
|
 |
Bethesda, MD |
 |
04/22/2009 |
 |
 |
 |
 |
 |
Details |
 |
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
|
 |
Bethesda, MD |
 |
04/22/2009 |
 |
 |
 |
Details |
 |
An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-Grade Glioma |
 |
Bethesda, MD |
 |
04/15/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Multicenter Prospective Analysis of Treatment Outcomes in Patients with Large Acoustic Neuromas Receiving Subtotal Resection with Back up Stereotactic Radiation Therapy |
 |
Cincinnati, OH |
 |
04/06/2009 |
 |
 |
 |
Details |
 |
Phase III Randomized, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Subjects to Compare the Efficacy of AZD2171 [RECENTIN] Monotherapy and the Combination of AZD2171 with Lomustine to the Efficacy of Lomustine Alone |
 |
Cincinnati, OH |
 |
04/06/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase III double blind, placebo controlled study of donepezil in irradiated brain tumor patients |
 |
Houston, TX |
 |
04/03/2009 |
 |
 |
 |
Details |
 |
Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection |
 |
Santa Monica, CA |
 |
11/29/2008 |
 |
 |
 |
 |
 |
Details |
 |
Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
|
 |
Cleveland, OH Cleveland, OH |
 |
11/19/2008 |
 |
 |
 |
Details |
 |
A Phase II Trial of Thalidomide in combination with Temozolomide or CPT-11 in patients with recurrent anaplastic gliomas or glioblastoma multiforme
|
 |
Houston, TX |
 |
10/27/2008 |
 |
 |
 |
 |
 |
Details |
 |
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma
|
 |
Boston, MA New York, NY Houston, TX Charlottesville, VA |
 |
10/09/2008 |
 |
 |
 |
Details |
 |
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors |
 |
Charlottesville, VA |
 |
09/30/2008 |
 |
 |
 |
 |
 |
Details |
 |
AutoLITT™ FIM Trial - A Prospective First-In-Man (FIM) Safety Trial of the AutoLITT Laser Treatment of Recurrent/Progressive Brain Tumors |
 |
Cleveland, OH |
 |
09/28/2008 |
 |
 |
 |
Details |
 |
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer |
 |
New York, NY Houston, TX San Antonio, TX |
 |
07/24/2008 |
 |
 |
 |
 |
 |
Details |
 |
Gliogene: An International Brain Tumor Study |
 |
Houston, TX |
 |
07/24/2008 |
 |
 |
 |
Details |
 |
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
|
 |
Houston, TX |
 |
04/15/2008 |
 |
 |
 |
 |
 |